
UK Pharmaceutical industry at risk from government's 'sky-high and unpredictable' rebates system
By CALUM MUIRHEAD Updated: 17:00 EDT, 11 June 2025 The UK’s status as a leader in medical research is at risk from ‘sky-high and unpredictable’ repayments pharmaceutical firms hand the Government, says an industry boss. Richard Torbett, chief executive of …